Methods and compositions for treating androgen-dependant diseases using optically pure R-(-) casodex
US5985868A · kind A · utility
42Cited by
0References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 30, 1998 |
| Grant date | Nov 16, 1999 |
| Priority date | — |
| Expiry date | Jun 30, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and compositions are disclosed utilizing optically pure R-(-)-casodex for the treatment of androgen-dependent prostate cancer, while substantially reducing the concomitant liability of adverse effects associated with the racemic mixture of casodex. R-(-)-casodex is an antiandrogen and is therefore useful in the treatment of other conditions supported by androgen or caused by elevated androgen levels. Such conditions include benign prostatic hypertrophy or hyperplasia, acne and hirsutism.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.